Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

National Institute of Mental Health

Division of US Department of Health and Human Services

Latest From National Institute of Mental Health

Venture Funding Deals: Innovent Sets Financing Record In China

The firm’s $260m Series D is the largest ever for biopharma in China and one of the biggest of the year worldwide; other notable financings go to Biohaven, Kymab and Magenta. Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced October through early December.

StartUps and SMEs Financing

Ketamine In The Era Of Neurobiology

BioPharmaceutical

Out Of The Wilderness: A Second Chance For Neuropsychiatric R&D?

The reorientation of Big Pharma neuroscience R&D toward a biology-driven approach is creating new hope for the treatment of psychiatric disorders.

BioPharmaceutical Research and Development Strategies

Pfizer Trial Could Take Akili Game Platform Into Digital Health Mainstream

Akili Interactive plans rigorous clinical trials for its mobile gaming app “Project EVO,” amassing empirical observations in the context of the mainstream medical enterprise, where developers believe it will be effective as both a clinical tool and a therapeutic.

Medical Device Research and Development Strategies
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register